Showing 1561 - 1570 of 2237 results

Showing Results for: “Glycemic Index and Diabetes”

COVID Fears Kept One in Five People With Diabetes Away From the Doctor During Pandemic

Growing reports of dangerous new health conditions, hard-to-manage blood sugar now emerging. A new study released today by the American Diabetes Association® in partnership with dQ&A, finds that growing numbers of people with diabetes have not only been forced to put off needed medical care since the outbreak of COVID-19, but that alarming numbers are struggling to manage their blood glucose levels. Key survey results found: Nearly 1 in 5 Americans with diabetes have skipped doctor’s appointments since the start of the pandemic, principally due to fear of contracting the virus; 1 in 4 people

Exceptional Leaders in Diabetes Research, Prevention and Treatment to be Recognized at ADA’s 81st Scientific Sessions

The American Diabetes Association® (ADA) is honored to announce the recipients of the 2021 National Scientific and Health Care Achievement Awards . The awards recognize academics, health care providers and educators who have contributed to tangible advances in the field of diabetes care and research. Each of these leaders have unwavering dedication to achieving the mission of the ADA: life free of diabetes and all its burdens. “I am thrilled to recognize the eight remarkable individuals receiving the ADA’s National Scientific and Health Care Achievement Awards,” said Tracey D. Brown, Chief

American Diabetes Association® Welcomes 2021 Principal Officers and New Members to National Board of Directors

The American Diabetes Association (ADA) welcomes the 2021 Principal Officers and Board of Directors. The 17-member board is comprised of forward-thinking, innovative medical, scientific, education and executive business professionals, who will strategically lead and focus efforts to ensure the ADA continues to uphold the mission upon which it was founded. "I am so excited to announce our 2021 Board of Directors, including five new Board members,” said Tracey D. Brown, Chief Executive Officer of the ADA. “I look forward to the insight and skills that each of these thought leaders will provide

American Diabetes Association Applauds the Ending Health Disparities during COVID-19 (EHDC) Act

The bill from Rep. Robin Kelly (D-IL) extends protections to low-income and minority communities during COVID-19 The American Diabetes Association® (ADA), the nation’s leading organization for all people living with diabetes, announced its support today for the Ending Health Disparities during COVID-19 (EHDC) Act, introduced by Representative Robin Kelly (D-IL). The list of bill cosponsors includes Reps. Karen Bass (D-CA), Joaquin Castro (D-TX), Judy Chu (D-CA), Jesús “Chuy” García (D-IL), Deb Haaland (D-NM), Barbara Lee (D-CA), Darren Soto (D-FL), Terri Sewell (D-AL), G.K. Butterfield (D-NC)

American Diabetes Association Praises the COVID-19 Testing, Reaching, And Contacting Everyone (TRACE) Act

Bipartisan King-Murkowski bill allocates testing resources for communities most at-risk The American Diabetes Association® (ADA), the nation’s leading organization for all people living with diabetes, announced its strong support for the COVID-19 Testing, Reaching, And Contacting Everyone (TRACE) Act in a letter to Senators Angus King (I-ME) and Lisa Murkowski (R-AK), who introduced the bill. The ADA also called on all Members of Congress to support this important legislation. The bill ensures that local organizations get the resources they need to mobilize testing and contact tracing efforts

ADA Fights for Right to Vote for People with Diabetes and Other Chronic Health Conditions During Pandemic

In Wisconsin, the ADA’s “friend of the court” brief urges changes be made to give those with diabetes and other chronic conditions safer access to vote On Monday, The American Diabetes Association® (ADA) filed an amicus curiae, or “friend of the court” brief in the federal court case Edwards et al. v. Vos et al. in the U.S. District Court for the Western District of Wisconsin, alleging that key changes are needed to enable people with diabetes and other chronic diseases to vote safely in this year’s elections. Proceeding without these changes would violate the U.S. Constitution and the

American Diabetes Association® Applauds Assembly Health Committee for Approving Insulin Price Reduction Bill

Today, the California Assembly Health Committee passed Assembly Bill 2203 (Nazarian), legislation that will cap insulin co-pays at $50 per 30-day supply of insulin and total out-of-pocket costs for insulin at $100 for those in state-regulated health insurance plans. The legislation also authorizes the California Attorney General to investigate the rising price of insulin in the state. The American Diabetes Association (ADA) is sponsoring the legislation along with the Health Trust. “The American Diabetes Association is appreciative of the support of our bill author Assemblymember Adrin

The American Diabetes Association Announces the 2024 National Scientific and Health Care Achievement Award Winners  

The American Diabetes Association® is pleased to announce this year’s National Scientific and Health Care Achievement Award recipients. The awards honor academics, health care providers, and educators who have contributed to substantial advances in diabetes care and research. “The diligent work of these passionate professionals is moving us closer to a world free of diabetes. Their contributions to research, prevention, and treatment are creating lasting change and improving the lives of people affected by diabetes,” said Charles “Chuck” Henderson, chief executive officer of the American

Breakthrough Studies on Automated Insulin Delivery and CGM for Type 2 Diabetes Unveiled at ADA Scientific Sessions

Results Demonstrate Enhanced Diabetes Management and Quality of Life with Advanced Technology New data focused on advanced technology innovations for managing type 2 diabetes (T2D) highlight the positive impact of automated insulin delivery systems (AID) and continuous glucose monitoring (CGM) in improving glycemic control and overall diabetes management. Three studies showing advancements for type 2 diabetes were presented at the American Diabetes Association’s ® (ADA) 84th Scientific Sessions in Orlando, FL. Of the nearly 40 million Americans with diabetes, more than 90% have type 2 diabetes

One in Four Patients with Difficult-to-Control Type 2 Diabetes Experience High Levels of Cortisol

Largest-Study-of-its-Kind Uncovers Potential Underlying Condition for People with Difficult-to-Control Type 2 Diabetes and Need for Improved Screening and Treatment Approaches Today, findings from the CATALYST study reveal that hypercortisolism may be a significant factor for why type 2 diabetes (T2D) remains difficult to control for many patients. This study found that 24% of individuals with difficult-to-control type 2 diabetes have hypercortisolism, a condition characterized by high cortisol levels. The results were presented as a late-breaking symposium today at the 84th Scientific